PEIJIA-B (09996) Chairman Zhang Yi increased his stake in the company by no more than HK$ 15 million.
Pai Health (09996) announced that the board of directors learned that Dr. Zhang Yibo, executive director, CEO, and chairman of the board of directors of the company, has started purchasing company shares on the open market through his controlled company starting from December 1, 2025. The total expected cost of increasing shareholding is not expected to exceed 15 million Hong Kong dollars.
PEIJIA-B (09996) announced that the Board of Directors has been informed that Dr. Zhang Yi, an executive director, CEO, and Chairman of the Board of Directors of the company, has started purchasing the company's shares on the open market through a company controlled by him, starting from December 1, 2025. The total expected cost of the increased shareholding is not expected to exceed HK$15 million.
According to Dr. Zhang, the increase in shareholding reflects his recognition of the company's intrinsic value and his strong confidence in the company's development prospects and growth potential. Dr. Zhang does not rule out the possibility of further increasing his shareholding in the company at the appropriate time in accordance with applicable laws and regulations.
Related Articles

Huatai (06886): "22 Huatai 11" will pay interest on December 12th.

FLOWING CLOUD (06610) reduced 2.47 billion shares due to share consolidation.

ShenZhen HuiJie Group (002763.SZ): understance brand terminates operation.
Huatai (06886): "22 Huatai 11" will pay interest on December 12th.

FLOWING CLOUD (06610) reduced 2.47 billion shares due to share consolidation.

ShenZhen HuiJie Group (002763.SZ): understance brand terminates operation.






